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It is estimated that over 150,000 patients will be diagnosed with invasive breast 
cancer in 2007.  Patients must undergo a mastectomy or a lumpectomy to remove the 
cancerous tissue, but only a mastectomy allows breast reconstructive surgery.  Due to the 
limitations of current reconstruction options, new alternatives are being explored.  
Injectable materials have been suggested for breast tissue reconstruction because of their 
versatility.  Cells cultured on injectable beads form cell carriers that may be mixed with a 
hydrogel, resulting in a construct that may be injected through a syringe to restore normal 
tissue mass.  This solution offers breast cancer patients a new reconstructive option that 
employs their own healthy cells. 
 The long-term objective, beyond the scope of this research, is to develop a novel 
injectable composite system, consisting of cellular scaffolds in a hydrogel carrier that 
could be injected into a defect site.  The primary goal of this research was to develop 
viable polymer scaffolds for preadipocyte growth and differentiation and to assess the 
cellular response to these scaffolds.  Initially, collagen-polylactide beads were developed 
and seeded with fibroblasts.  The fibroblasts had a high affinity for these beads, but 
collagen was not conclusively proven to be present in the microspheres.  Subsequently, 
polylactide beads with collagen or collagen and linoleic acid coatings were produced.  
Preadipocytes were grown on the collagen and collagen/linoleic acid coated beads, 
uncoated polylactide beads, or two 2-D controls, and tested for viability, lipid and fatty 
acid production, and gene expression.  Few cells were capable of attaching and 
proliferating on the uncoated polylactide beads for the entire 18-Day culture period; 
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however, more cells were able to attach and proliferate on both types of coated 
microcarriers.  Cell produced more triglyceride on Day 18 of culture on the beads coated 
with collagen than the polylactide beads or the polylactide beads coated with collagen 
and linoleic acid.  Cells grown on both types of coated beads produced more fatty acids 
on Day 18 than cells grown on the polylactide beads.  The coated beads show potential 
for use in the injectable composite system as cellular carriers; however, the polylactide 
beads may be better suited for an alternative purpose in this system.  Future work is 
needed to optimize the linoleic acid concentration as well as to examine other fatty acids 
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 Current methods of reconstructing breast tissue after a mastectomy or 
lumpectomy are limited, so new methods are being researched.  Of particular interest is 
tissue engineering a minimally invasive device, such as an injectable biomaterial, to 
restore the breast tissue without the need for a second surgery.  This method will reduce 
the pain, scarring, recovery time, and cost that usually occur with reconstructive surgery.  
Scaffolds for use in injectable devices are being designed and researched for their ability 
to control cellular activity, encourage tissue growth, and provide a temporary filler until 
the devices can be replaced by native tissue. 
 The purpose of this research was to add collagen and linoleic acid to polylactide 
microspheres and evaluate the cellular response to such microspheres.  Two studies were 
conducted.  First, collagen-polylactide beads were manufactured and tested for their 
cellular affinity.  Second, polylactide beads were coated with collagen or with collagen 
and linoleic acid.  Cells on both types of coated beads were tested for cell viability, 
triglyceride and fatty acid production, and gene expression, and the results were 






 Breast cancer is the second most common cancer among women, second only to 
nonmelanoma skin cancers.  The American Cancer Society estimates that 178,000 new 
cases of invasive breast cancer will occur in women in the US during 2007 [1].  Several 
potential courses of treatment are considered for these patients.  Surgery and therapeutic 
options, such as radiation therapy, chemotherapy, and hormone therapy, are considered to 
be the standard treatments to remove a tumor.  Most patients with breast cancer have 
surgery to remove the cancerous tissue; the two most common surgeries are lumpectomy 
and mastectomy.  A lumpectomy is a breast conserving surgery, which removes the 
tumor and a small margin of normal tissue around it, but for which there are no 
reconstructive options available.  A mastectomy removes the entire breast that contains 
cancer, and allows the patient to undergo breast reconstruction. 
 
Breast Tissue Biology 
Adipose tissue comprises most of the normal breast and is removed during 
mastectomy.  This tissue is highly vascularized and has an extensive vascular network.  
The volume of an adipocyte is 80 to 95% triglyceride, which is a type of lipid.  Mature 
adipocytes are terminally differentiated and cannot proliferate, but can increase in size.  
Preadipocytes have been investigated for adipose tissue engineering because these cells 
are committed to the adipocyte lineage and can increase in number [2].  Preadipocytes 
can be advantageous because of their proliferative capacity and ability to differentiate and 
form adipose tissue.  In vitro, preadipocytes are fibroblast-like in appearance and this 
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shape is maintained throughout cellular proliferation.  When preadipocytes undergo 
differentiation, proliferation is halted and the cells undergo morphological and 
biochemical changes [2].  The maturing cells acquire a spherical shape, accumulate 
triglyceride, and exhibit mature adipocyte phenotypes.  
During the differentiation process, preadipocytes begin to express genes that are 
characteristic of adipocytes.  Preadipocytes express the gene growth arrest and DNA-
damage inducible protein (GADD) 153, also designated C/EBP-homologous protein zeta, 
(CHOP-10), which blocks the cell from transitioning from the G1 to the S phase of the 
cell cycle [3].  This gene inhibits adipocyte differentiation, and is down regulated as 
differentiation begins [3, 4].  Early in the differentiation stages peroxisome proliferator 
activator receptor gamma, PPAR-γ, is expressed and levels increase as differentiation 
progresses to later stages [2, 4].  PPAR-γ is a nuclear hormone receptor [4, 5, 6] that 
promotes and regulates adipogenesis [5, 7, 8].  Adipocyte-specific fatty-acid-binding 
protein-2 (aP-2) is a lipid binding protein [9] expressed in mature adipocytes [4, 6, 8].  
 
Traditional Methods of Breast Reconstruction 
 According to the American Society for Plastic Surgeons, over 50,000 women 
opted for reconstructive surgery in 2006 [10].  The goals of reconstruction are to regain 
breast contour and chest symmetry, and to help women avoid the feeling of having a 
deformity.  Reconstruction options include acellular and cellular approaches, which have 
their associated complications and disadvantages. 
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Acellular options include prostheses, tissue expanders, and implants that are all 
available commercially.  Prostheses are worn outside the body and give a natural 
appearance when worn under clothing; prostheses lend a non-surgical option.  These 
devices are mobile and therefore limit the patient’s physical activity; additionally, 
prostheses may appear distorted at times.  A tissue expander necessitates a surgical 
procedure where an empty silicone shell is placed under the muscle wall.  The shell is 
filled with saline over a period of weeks to months until it is inflated to the proper size.  
The shell is then deflated and removed; the void is filled with a permanent implant.  Risk 
of infection, damage to the expander, discomfort of expansion, a second operation, and a 
longer period of reconstruction are all potential negative outcomes following tissue 
expansion and reconstruction [11, 12].  Breast implants are silicone shells filled with 
either silicone or saline that may be implanted during or after the initial surgery.  
Common complications include rupture and subsequent removal of the implant.  Scar 
tissue may contract and form a hard capsule around the implant, in rare cases masking the 
recurrence of breast tumors.  
Cellular reconstructive options were initiated with the investigation of autologous 
adipose tissue for soft tissue repair.  Adipose tissue is found in abundance in many 
patients, and is easily harvested [12].  However, when implanted, an adipose tissue graft 
volume decreases by 50-70% due to resorption of the tissue [12].  Adipocytes are 
anchorage-dependent cells and will not survive without a scaffold on which to grow.  
Mature adipocytes cannot grow to replenish the cells lost to resorption because they are 
terminally differentiated [12].  A tissue flap is a section of autologous tissue consisting of 
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skin, fat and/or muscle that is transplanted to the breast area [12].  The flap can be shaped 
to approximate the size and feel of a normal breast [13].  There are two main types of 
flaps; a TRAM flap and a Latissimus flap.  The TRAM (transverse rectus abdominus 
musculocutaneous) flap is the most commonly excised flap.  The abdominal wall skin, 
rectus abdominus muscle, and subcutaneous adipose tissue, along with the blood vessels 
that supply these tissues are moved to the chest to recreate the breast mound [12].  The 
Latissimus flap, including the latissimus dorsi muscle of the back, along with the skin and 
fat in the area, is moved to recreate the breast mound.  This type of reconstruction 
minimizes foreign body response, and the reconstructed site more closely approximates 
the feel of a normal breast as opposed to an inert implant [13].  Donor-site morbidity, 
abdominal wall weakness or latissimus dorsi muscle atrophy at the donor site, and longer 
recovery times are the primary drawbacks of this surgery.  These reconstruction options 
restore tissue volume, but do not restore tissue function or create a viable tissue mass. 
 
Tissue Engineering as a Method of Breast Reconstruction 
 Tissue engineering strategies are being investigated for breast tissue 
reconstruction.  This multidisciplinary field focuses the application of engineering and 
life science concepts toward the development of biological substitutes that restore, 
maintain, or improve tissue function [14].  Ideally, the engineered tissue integrates with 
the host tissue and new native tissue is created.  The goal of breast tissue engineering is to 
create a volume of viable adipose tissue using the patient’s cells as the building blocks.  
Direct autologous fat tissue transplantation is minimally successful because a significant 
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portion of the transplanted tissue resorbs over time leading to visible deformities [15].  
Current tissue engineering strategies include scaffold guided tissue regeneration (e.g., 
injectable composite system), tissue based regeneration (e.g., fragmented omentum), and 
tissue induced regeneration (e.g., de novo adipogenesis) [15].   
 
Breast Tissue Engineering Scaffolds 
Scaffolds employed in adipose tissue engineering need to meet certain criteria.  
The scaffold should facilitate the growth of tissue that has the natural feel of the normal 
tissue and should conform to the defect site in the original tissue [16, 17].  A viable 
scaffold should be biocompatible, facilitate cell adhesion, promote cell growth, and act as 
a guide for the three-dimensional growth of cells [16, 17].  The scaffold porosity should 
be sufficient for cell adhesion and tissue ingrowth; the scaffold should have a large 
surface to volume ratio and should be eliminated completely and replaced by native 
tissue over a period of time [16, 17, 18].  The scaffold should degrade at a rate that allows 
the timely development of new tissue formation.  Absorbable scaffolds are advantageous 
because they eliminate the need for a retrieval surgery and their absorption minimizes the 
possibility for long-term biocompatibility issues.  
Preadipocytes and adipocytes are anchorage-dependent cells; i.e. they require a 
biomechanically acceptable substrate in order for normal cell proliferation and 
differentiation to occur [19].  Scaffolds can be derived from naturally occurring or 
synthetic materials.  Naturally occurring materials currently under investigation include 
collagen, gelatin, fibrin, alginate, hydroxyapatite, and chitosan [16, 20-22].  Natural 
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polymers are biocompatible, mimic the biochemical structure of the native cellular 
environment, and are degradable by enzymatic or hydrolytic mechanisms [22].  
Unfortunately, natural materials have many disadvantages, including relatively high 
antigenicity, batch to batch variation, and increased risk of transfer of infectious disease.  
The most widely used synthetic materials in tissue engineering applications are polymers 
[16, 17, 21, 22].  Synthetic polymers are desirable because they have very little variability 
from batch to batch, have a wide spectrum of properties, and have tunable degradation 
rates.  These materials can also be processed into a variety of shapes, such as sponges, 
films, and microspheres.  
 
Absorbable and Degradable Polymers 
Absorbable polymers are those plastics that are degraded and removed from the 
body, while degradable polymers are remodeled and remain in the body.  One of the well 
known, synthetic absorbable polymers used is polylactide (PL) [16].  The US Food and 
Drug Administration has approved PL for human use in absorbable sutures and some 
implantable devices.  PL has various forms, including poly-L-lactide (PLL), poly-D-
lactide (PDL) and poly-D,L-lactide (PDLL).  PLL and PDL are semicrystalline polymers 
while PDLL is an amorphous polymer.  All three forms degrade through hydrolysis to 
lactic acid, a normal metabolite that is found in the body and is excreted from the body as 
water and carbon dioxide.  Select material properties that determine the rate of hydrolysis 
are outlined in Table 1.1.  Sterilization method and environmental factors such as 
biochemical agents, pH, and temperature will all influence the rate of hydrolysis.  
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Polylactides can be made with a variety of properties, allowing them to be used in a large 
range of applications.  PL can be fabricated into many forms, such as sponges [16], 
woven or knit meshes [16], microparticles [23], and films [24].  For PL to be successfully 
used as a cellular substrate for adipose tissue engineering, preadipocytes and adipocytes 
must be able to adhere to and proliferate and/or differentiate on the scaffold.  Conejero 
and coworkers seeded fat-derived stem cells onto a PL scaffold and showed that the cells 
were able to grow and form a tissue [25]; however, PL is not an ideal scaffold to use as a 
cell carrier because it is hydrophobic and releases acidic byproducts as it degrades, 
causing the pH of the local environment to decrease.  Even though cells do eventually 
grow on PL, surface modification of this polymer could allow the cells a more hospitable 
surface, leading to immediate cell growth. 
 








 Synthetic materials alone will likely not create a proper cellular environment.  
Natural materials combined with synthetic materials likely provide the ideal environment 
for cells, i.e. an environment that is structurally sound and conducive to adhesion and 
proliferation.  Collagen, a degradable material that is remodeled in vivo by collagenase, 
has been widely used in medical applications for many years and plays an important role 
in the formation of tissues.  Collagen is a crosslinked protein found throughout the human 
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body that is biodegradable, nontoxic, and has weak antigenecity.  The properties of 
collagen are directly affected by the density of crosslinking and the type of crosslinking 
agent employed [26].  Glutaraldehyde is the most commonly used crosslinking agent 
because it is inexpensive and provides sustained long-term durability by creating a high 
density of covalent crosslinks [26, 27].  Unfortunately, this chemical is thought to cause 
long-term cytotoxicity as well as calcification.  If no crosslinking agent is used, collagen 
is degraded in the body too quickly to be clinically viable. 
 Tannic acid is a plant polyphenol that has the ability to crosslink proteins and is 
rumored to have anti-carcinogenic properties.  Tannic acid is capable of crosslinking 
proteins because it contains a large number of functional groups.  Specifically, hydrogen 
bonds form between the phenolic hydroxyl groups on the tannic acid and the carboxyl 
groups of the protein [28] thus binding the protein.  Hydrogen bonds are lower energy 
bonds than covalent bonds; therefore, a tannic acid crosslinked collagen will degrade 
relatively fast as compared with a glutaraldehyde crosslinked collagen.  Tannic acid is 
reported to be an anticarcinogen for certain types of cancer, including mammary cancer, 
and is an effective inhibitor of tumors in mice [28].  Tannic acid crosslinking allows the 
collagen to degrade within a reasonable time, while also potentially reducing the chances 
of tumors recurring. 
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Composite Injectable Systems 
 An injectable composite system is of particular interest because it is mechanically 
similar to soft tissue, conforms to irregular spaces, and may be implanted in a minimally 
invasive manner [29].  The composite system is composed of two distinct parts, a rigid 
absorbable scaffold for cell attachment and growth, and an absorbable gel to facilitate the 
scaffold delivery, as shown in Figure 1.  The scaffold should have a diameter smaller 
than the gauge of a needle in order to allow injection.  This tissue engineering strategy 
can be modified so scaffolds of varying properties are embedded within the same 
hydrogel to obtain a tunable drug delivery system and tailored absorption profile.  
Composite systems, by virtue of their discrete scaffold structure, allow tissue integration 
and vascularization within the construct as well as serial implantation, and thus may 
allow the reconstruction of larger volumes of tissue than the traditional continuous 
scaffolds which are diffusion limited [29].  
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Figure 1.1  The development of injectable composite devices for breast tissue 
reconstruction 
 
Maintenance of Adipose Tissue Long-Term 
 Collagen and PL are effective scaffolds for cell attachment and proliferation, but 
differentiation will be key to the long-term maintenance of soft tissue bulk.  Satory and 
coworkers investigated the effects of conjugated linoleic acid, as a medium additive on 
preadipocyte proliferation and lipid filling [30].  Their results showed that certain 
concentrations of conjugated linoleic acid in the medium inhibited preadipocyte 
proliferation and increased cellular lipid content.  Although there are differences between 
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conjugated linoleic acid and linoleic acid, there is not enough detailed research to 
determine the effects of each different type of linoleic acid on cellular attachment and 
growth.  Based upon these results, this study hypothesizes that inclusion of lipid into an 
injectable composite system might allow preadipocytes seeded on the scaffolds to 
differentiate once injected into the body, while stimulating adipocytes present in the 
tissue to retain cellular lipid.  Conjugated linoleic acid has also been shown to be 
anticarcinogenic in a rat mammary tumor model [31] 
 The long-term goal, beyond the scope of this work, is to develop an injectable 
biodegradable composite breast tissue reconstruction device with anti-tumor and bulking 
capabilities.  This study focuses on designing polymer scaffolds that are viable for 
preadipocyte growth and differentiation.  Polylactide beads were coated with collagen 
and linoleic acid, then seeded with preadipocytes and observed in vitro to assess cell 
attachment, growth, and differentiation patterns. 
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MATERIALS AND METHODS 
 
 
 To meet the objectives of this research, two primary studies were performed.  The 
first study determined cell viability on collagen encapsulated polylactide beads.  The 
second study examined cell viability and differentiation on collagen coated polylactide 
beads and collagen and linoleic acid coated polylactide beads. Metabolic activity, lipid 
and fatty acid production, cell viability, and gene expression of cells were compared 
between the coated polylactide beads, uncoated polylactide beads and 2-D surfaces. 
 
Polylactide scaffolds 
Solution Preparation for Emulsion-Solvent Evaporation 
 Polylactide (PL) pellets were obtained from DOW chemicals (DOW LLC, 
Minneapolis, MN).  A 10% w/v solution of PL was prepared by dissolving 2 grams of PL 
pellets into 20 mL of dichloromethane (Mallinckrodt Inc., Hazelwood, MO) for 48 hours.  
A 0.3% solution of PVA was created by adding 3 grams of PVA flakes (Sigma-Aldrich, 
St. Louis, MO) into 1000 mL of distilled water, then stirring and heating the solution over 
low heat until the PVA was completely dissolved.  The solution was then cooled to room 
temperature before use.  A 2% isopropanol solution was prepared by mixing 20 mL of 
isopropanol (VWR, West Chester, PA) with 980 mL of distilled water. 
 
Fabrication Equipment and Procedure 
Scaffolds were prepared using an emulsion-solvent evaporation procedure.  A 
glass tank measuring 24 cm in diameter and 28 cm in height, with a drain located in the 
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bottom that was covered with a brass WireMesh® screen (Paragona®, Stockholm, 
Sweden), was elevated on two 2” x 4” risers.  Tygon R-3603 tubing (Saint-Gobain 
Performance Plastics, Akron, OH) was connected to both the drain at the bottom of the 
tank and to the drain in the chemical hood.  A paddle stir rod connected to a EUROSTAR 
power control-visc overhead stirrer (IKA® Works, Wilmington, NC) was placed over the 
tank.  A solution of 1000mL of 0.3% PVA and 5000mL of distilled water were mixed 
together in the tank to form a 0.05% v/v solution of PVA.  The solution was stirred for 5 
minutes at 200 rpm. 
Twenty mL of 10% PL solution were then poured into a 20cc syringe (BD, 
Franklin Lakes, NJ) with an attached 16-gauge needle (BD).  The needle was submerged 
in the 0.05% PVA solution near the vortex created by the stir rod, and the PL solution 
was injected into the PVA solution.  The solution of PVA and PL was stirred for 10 
minutes at 275 rpm.  Once the microspheres were settled to the bottom of the tank, 2/3 of 
the PVA solution was drained.  Two liters of 2% isopropanol solution were added to the 
tank, and then stirred for 5 minutes at 200 rpm to wash the microspheres.  The tank was 
drained until approximately 1 liter remained.  The microspheres and liquid were then 
transferred to a 1L glass Pyrex® bottle (Corning, Inc., Corning, NY) using a vacuum 
source connected to a 45 mm 3-Port for medium bottles (Bellco Glass, Inc., Vineland, 
NJ) by Tygon tubing (Saint-Gobain Performance Plastics).  The liquid in the bottle with 
the microspheres was removed, and replaced with 200 mL of fresh 2% isopropanol 
solution.  The bottle was then placed on an orbital shaker (IKA® Works) and shaken at 
150 rpm overnight at room temperature.  The microspheres were then dried on a Coors® 
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Bichner filter funnel (Fisher Scientific, Fair Lawn, NJ), which had a cellulose grade 1 
filter paper (Whatman®, Florham Park, NJ) in place.  The filter funnel was inserted into a 
500 mL Kimax Erlenmeyer filter flask (Chemglass, Vineland, NJ) and connected to a 
compressed air system.  The air was circulated over the microspheres for a few hours, 
until the microspheres were completely dried, as evidenced by their shiny appearance.  
The dry microspheres were transferred to a scintillation vial (Fisher Scientific) and stored 




Polylactide Microspheres with Entrapped Collagen 
 Collagen (Invitrogen, Carlsbad, CA) was solubilized by adding 1.5 mL of 
collagen to 167 µm of 10x DPBS (Invitrogen), 225 µL fetal bovine serum (FBS) 
(Mediumtech, Herndon, VA), 358 µL 1 x Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Invitrogen), and 20 µL 1N NaOH, creating 2.27mL of solubilized collagen.  
Two ratios of collagen to PL pellets were mixed, 50% collagen to 50% PL, referred to as 








Figure 1.2 PL scaffold fabrication setup: overhead stirrer (1), glass tank (2), drainage 
tubing (3), drain with mesh cover (4)  (A); filter setup to dry PL scaffolds: Buchner 
funnel (5), and compressed air (6)  (B) 
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mL of solubilized collagen was mixed with 5 mL of dichloromethane (Mallinckrodt Inc.) 
and 1 gram of PL pellets (Cargill DOW LLC) in a scintillation vial (Fisher Scientific) for 
48 hours.  For solution B, 2.27 mL of solubilized collagen was mixed with 6.75 mL of 
dichloromethane and 1.35 grams of PL pellets in a scintillation vial for 48 hours.  PVA 
solution and 2% isopropanol solution were prepared as previously described.  
Microspheres from these solutions were created using the emulsion-solvent evaporation 
technique outlined previously. 
 
Polylactide Microspheres Coated with Collagen 
 PL microspheres were created using the emulsion-solvent evaporation technique 
outlined previously.  A mixture of 6 grams of hexanediamine with 100 mL of isopropanol 
created a 6% hexanediamine/isopropanol solution.  To create a 0.1% tannic acid solution, 
0.1 gram of tannic acid was added to 100 mL of distilled water and the solution was 
stirred and heated to a simmer.  The solution was then allowed to cool to room 
temperature before use.  A collagen/acetic acid solution was created by adding 
solubilized collagen to 3% acetic acid (Fisher Scientific) at a ratio of 2:1. 
The microspheres were stored under vacuum for 3 Days and then added to a 6% 
hexanediamine/isopropanol solution and immersed into a 60°C water bath for 10 
minutes.  The solution was shaken continuously while in the water bath, to prevent the 
beads from adhering to the bottom of the flask.  The microspheres were placed on a 
cellulose grade 1 filter paper that was placed on a Coors® Bichner filter funnel that was 
inserted into a 500 mL Kimax Erlenmeyer filter flask, and washed extensively with 
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deionized water.  The microspheres were dried at room temperature under vacuum for 
several hours.  Once dried, the microspheres were immersed in 0.1% tannic acid solution 
at room temperature for 3 hours, and then washed extensively with deionized water.  The 
microspheres were then immersed into a 2:1 collagen/acetic acid solution for 24 hours at 
4°C, with occasional shaking.  After being washed with deionized water, the 
microspheres were placed under vacuum until use.  These beads will be referred to as 
PL+C beads. 
 
Polylactide Microspheres Coated with Collagen and Linoleic Acid 
 PL microspheres were created using the emulsion-solvent evaporation technique 
outlined previously.  A mixture of 6 grams of hexanediamine and 100 mL of isopropanol 
created a 6% hexanediamine/isopropanol solution.  To create a 0.1% tannic acid solution, 
0.1 gram of tannic acid was added to 100 mL of distilled water, and the solution was 
stirred and heated to a simmer.  The solution was then allowed to cool to room 
temperature before use.  A collagen/acetic acid/linoleic acid solution was created by 
adding solubilized collagen to 3% acetic acid at a ratio of 2:1 to a volume of 3 mL, then 1 
mL of linoleic acid bound to bovine serum albumin (Sigma-Aldrich) was added to the 
solution and stirred. 
The microspheres were stored under vacuum for 3 Days and then added to a 6% 
hexanediamine/isopropanol solution and immersed into a 60°C water bath for 10 
minutes.  The solution was shaken continuously while in the water bath to prevent the 
beads from adhering to the bottom of the flask.  The microspheres were placed on a 
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cellulose grade 1 filter paper that was placed on a Coors® Bichner filter funnel and 
inserted into a 500 mL Kimax Erlenmeyer filter flask, and washed extensively with 
deionized water.  The microspheres were dried at room temperature under vacuum for 
several hours.  Once dried, the microspheres were immersed in 0.1% tannic acid solution 
at room temperature for 3 hours, and then washed extensively with deionized water.  The 
microspheres were then immersed into a collagen/acetic acid/linoleic acid solution for 24 
hours at 4°C, with occasional shaking.  After being washed with deionized water, the 




Stir Flask  
 DMEM (Invitrogen) was supplemented with Fetal Bovine Serum (FBS), L-
glutamine, fungizone, and antibiotic-antimycotic.  Six Wheaton Celstir spinner double 
side arm flasks (Fisher) were used; three flasks for PL beads, and three flasks for PL 
beads with entrapped collagen.  The walls of the stir flasks were coated with 0.15% 
agarose solution (Sigma-Aldrich) to prevent the cells from adhering to the walls of the 
flasks.  3T3-M mouse fibroblasts were cultured with supplemented DMEM in a Wheaton 
Celstir spinner double side arm flask (Fisher).  To each stir flask containing 50 mL of 
supplemented DMEM medium, 4x106 cells, and 1.75 mL of either PL beads or PL beads 
with entrapped collagen were added.  Assays were performed at Day 7 and Day 13. 
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2-D Cell Culture 
 3T3-L1 mouse preadipocytes were cultured on 12-well polystyrene plates 
(Corning® Inc.) with 1.5 mL of DMEM-C (Invitrogen) in each well.  Initially, 3.125x105 
cells were seeded in each well.  The cells were cultured at 37°C and 5% CO2, and the 
medium was changed every 2 Days. 
 
3-D Cell Culture 
 3T3-L1 cells were cultured with DMEM-C (Invitrogen) on 12-well ultra low 
cluster plates.  The wells were coated with 0.15% agarose solution (Sigma-Aldrich) to 
prevent the cells from adhering to the wells.  To each of 4 wells, 100 µg of microspheres, 
3.1x105 cells, and 1.5mL of DMEM-C were added.  The microspheres tested in this assay 
were the PL beads, PL+C beads, and PL+C+L beads.  Assays were performed at Days 4, 
10, and 18 using 4 wells per microsphere type per plate.  Figure A-1 shows which wells 




PL microspheres with entrapped collagen were characterized using Fourier 
Transform Infrared Spectroscopy (FTIR), and Gomori’s One Step Trichrome.  Also, the 
microspheres were examined and measured using an inverted microscope. 
Fourier Transform Infrared Spectroscopy  
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 FTIR was performed to identify if collagen was present in the collagen 
encapsulated microspheres.  The samples were placed onto the Thermo-Spectra-Tech 
Foundation Series Diamond ATR (Thermo Fisher Scientific, Inc., Waltham, MA), and 
compressed with the compression tower of the Diamond ATR. 
 FTIR spectra were collected using a Thermo-Nicolet Magna 550 FTIR 
spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA) equipped with a 
Thermo-Spectra-Tech Foundation Series Diamond ATR (Thermo Fisher Scientific).  The 
samples were scanned 16 times at a resolution of 4cm-1 from 4000 cm-1 to 525 cm-1 and 
ratioed against a background scan collected at the same parameters.  The data was 
analyzed using OMNIC ESP version 6.1a software. 
Gomori’s One Step Trichrome 
Gomori’s One Step Trichrome was used to determine if collagen was present in 
the beads.  The beads were placed in Bouin’s fixative (Fisher) overnight.  The beads were 
then washed with distilled water until the water ran clean then placed in Gomori’s One 
Step Trichrome stain for 20 minutes.  Then beads were transferred directly into 0.5% 
aqueous acetic acid for 2 minutes then differentiated in 1% aqueous acetic acid for 1 
minute.  The beads were rinsed in distilled water and dehydrated in 95% ethyl alcohol 
then absolute alcohol.  The beads were examined under a steromicroscope and collagen 
presence showed as a green coloring on the beads, which was measured qualitatively. 
PL coated scaffold properties were characterized using gel permeation 
chromatography, (GPC) (Waters, Milford, MA), differential scanning calorimetry (DSC) 
(TA Instruments, Inc., New Castle, DE), and gas chromatography (GC) (Agilent 
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Technologies, Foster City, CA).  The samples tested included PL pellets, PL scaffolds, 
PL scaffolds coated with collagen, and PL scaffolds coated with collagen and lipid. 
Gel Permeation Chromatography 
 GPC was conducted to determine the molecular weight and polydispersity of 
select PL scaffolds using a Waters HPLC system (Waters), consisting of a Model 610 
HPLC pump, a Waters Model 486 UV/Vis detector, and a Waters Model U6K injector.  
The samples were dissolved in HPLC grade chloroform (Burdick and Jackson, Miskegon, 
MI) at a concentration of 3mg/mL of sample to chloroform.  
Differential Scanning Calorimetry 
The Thermal properties of the PL were determined using a DSC Thermal Analyst 
2000 (TA Instruments, Inc.).  The sample weight ranged from 5-10 mg and the samples 
were contained in aluminum pans (Perkin Elmer, Wellesley, MA).  The samples were 
heated at a rate of 10°C/minute from 25°C to 200°C in the first cycle.  The samples were 
then quenched using liquid nitrogen.  Samples were reheated a second time to 200°C at a 
rate of 10°C/minute.  
Gas Chromatography 
 GC was used to determine the amount of fatty acid present in the linoleic acid and 
collagen coated PL microspheres.  A sample of 0.5 mg of microspheres was weighed and 
placed in a test tube; volumes of 300 µL of methylene chloride (Fisher Scientific) and 1 
mL of 0.5 N sodium methoxide in methanol (VWR) were added to the sample.  The tube 
was flushed with nitrogen and heated at 90°C for 10 minutes, then cooled to room 
temperature.  One mL of 14% boron trifluoride in methanol (EMD Chemicals, San 
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Diego, CA) was added to the sample and heated at 90°C for 10 minutes.  After the 
sample was cooled to room temperature, 500 µL of GC grade hexane (Fisher Scientific) 
and 500 µL of GC grade hexane containing the internal standard, C23:0 methyl ester (1 
mg/mL) (Sigma-Aldrich) was added to the sample.  Two mL of deionized water were 
added to the sample and the sample was vortexed for 2 minutes, then centrifuged at 1500 
x g for 5 minutes.  The upper layer of the test tube was transferred to a test tube 
containing a small amount of anhydrous sodium sulfate (Fisher Scientific).  The liquid 
was transferred to a GC vial and was run in the 6850 Series II Gas Chromatograph fitted 




Stir Flask LIVE/DEAD 
A LIVE/DEAD® Viability/Cytotoxicity Kit (Invitrogen) was used to qualitatively 
determine the cellular viability and the cellular attachment to the different microspheres.  
Under sterile conditions, the LIVE/DEAD® working solution was prepared according to 
the manufacturer’s instructions.  The scaffolds were transferred to a 24-well plate 
(Corning® Inc.) into separate wells.  Residual medium was aspirated from the scaffolds, 
and the scaffolds were rinsed with 1 mL sterile PBS (Sigma-Aldrich).  The PBS was 
aspirated and 1 mL of the working solution was added to each well.  The plate was 
incubated for 45 minutes at room temperature and protected from light.  Images of the 
scaffolds were captured using the Axiovert 135 fluorescent inverted microscope (Zeiss, 
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Thornwood, NY)), the SPOT INSIGHT color digital camera (Diagnostic Instruments, 
Sterling Heights, MI), and Image Pro Plus 4.5 software (Medium Cybernetics, Bethesda 
MD).  The wells were evaluated for green fluorescence, indicating viable cells, and red 
fluorescence, indicating non-viable cells.   
Cellular Imaging 
 Images of the cells on polystyrene and on each of the microsphere types were 
captured on Day 4, Day 10, and Day 18 using the Axiovert 135, Image-Pro 4.1 software, 
and a SPOT INSIGHT camera. 
Lactic Acid and Glucose Measurements 
 Lactic acid production and glucose consumption were measured before every 
medium change.  The lactic acid and glucose present in the medium were measured using 
a YSI 2700 SELECT Biochemistry Analyzer (YSI Inc., Yellow Springs, OH). 
LIVE/DEAD® Assay 
 A LIVE/DEAD® Viability/Cytotoxicity Kit (Invitrogen) was used to qualitatively 
determine the cellular viability and the cellular attachment to the different microspheres.  
Under sterile conditions, the LIVE/DEAD® working solution was prepared according to 
the manufacturer’s instructions.  The scaffolds were transferred to a new 24-well plate 
(Corning® Inc.) into separate wells.  Residual medium was aspirated from the scaffolds, 
and the scaffolds were rinsed with 1 mL sterile PBS (Sigma-Aldrich).  The PBS was 
aspirated and 1 mL of the working solution was added to each well.  The plate was 
incubated for 45 minutes at room temperature and protected from light.  Images of the 
scaffolds were captured using the Axiovert 135 fluorescent inverted microscope (Zeiss, 
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Thornwood, NY)), the SPOT INSIGHT color digital camera (Diagnostic Instruments, 
Sterling Heights, MI), and Image Pro Plus 4.5 software (Medium Cybernetics, Bethesda 
MD).  The wells were evaluated for green fluorescence, indicating viable cells, and red 
fluorescence, indicating non-viable cells.   
Triglyceride Assay 
 The total intracellular triglyceride concentration was determined using a 
differentiation assay protocol developed by Zen-Bio, Inc (Cultured Human Adipocyte 
Differentiation Assay Kit, Zen-Bio, Inc., Research Triangle Park, NC).  The medium was 
aspirated from each sample; each sample was then rinsed with 1mL of sterile PBS and 
the liquid aspirated.  The cells were frozen at -80°C for 1 hour and then thawed at 37°C 
for 10 minutes.  The freeze-thaw cycle was repeated twice.  One mL of 1% Triton X-100 
(Fisher Scientific) was added to each well to lyse the cells on the scaffolds.  The scaffolds 
were then incubated at room temperature for 30 minutes.  The triton solution with cell 
debris was transferred to a microcentrifuge tube and centrifuged for 10 minutes at 3000 
rpm.  Next, 100µL of each sample was pipetted into wells of a 96-well plate in triplicate.  
Glycerol standards with concentrations ranging from 0 to 200µM, shown in Table 1.2, 
were prepared by diluting glycerol with an appropriate volume of Nanopure water, then 
pipetted in triplicate into the remaining 96-well plate.  Subsequently, a volume of 100µL 
of InfinityTM triglyceride reagent (ThermoElectron Corporation, Melbourne, Australia) 
was added to each well of the plate that contained either a standard or a lysate sample.  
The plate was incubated at room temperature for 15 minutes.  The absorbances of the 
samples in the plate were read at 490 nm using a spectrophotometer (MRX Revelation 
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TC, Dynex Technologies, Chantilly, VA).  The resulting output included absorbances 
with respect to concentrations of the prepared glycerol standard solutions, and resulted in 
the generation of a standard curve. 
 






Amount of Water 
(µL) 
0 0 350 
3.125 0.38 349.62 
6.250 0.76 349.24 
12.5 1.50 348.50 
25.0 3.03 346.97 
50.0 6.1 343.90 
100 12.1 337.90 
200 24.2 325.80 
 
Gas Chromatography 
 Transmethylation of lipid extracts was performed on each of the samples to 
quantify the type and volume of lipid present in the cells.  Each sample underwent lipid 
extraction before being transmethylated.  For lipid extraction, the samples were moved to 
a glass tube.  A volume of 7.5 mL of 2:1 chloroform (Fisher Scientific) to methanol 
(Fisher Scientific) was added, then the tube and contents were vortexed for 3 minutes.  
The sample was filtered through a cellulose grade 1 filter paper (Whatman®, Florham 
Park, NJ ) into another tube containing 0.58% NaCl2 (Fisher Scientific).  The original 
tube was then rinsed with 2.5 mL of 2:1 chloroform: methanol, and filtered into the rest 
of the sample.  The tube was then capped and vortexed for 3 minutes, then centrifuged at 
1500 rpm for 5 minutes to separate the phases.  The upper layer of methanol and water 
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was siphoned off and discarded.  The lower layer was evaporated under nitrogen to 
dryness.  Next, the sample was transmethylated into the same tube in which the sample 
was evaporated.  To each sample, 300µL of methylene chloride (Fisher Scientific) and 
1mL of 0.5 N sodium methoxide in methanol (VWR) was added.  The tube was flushed 
with nitrogen, capped, and heated for 10 minutes at 90°C.  The samples were allowed to 
cool to room temperature then 1mL of 14% BFl3 in methanol (EMD, San Diego, CA) 
was added to each sample.  The samples were heated for 10 minutes at 90°C then cooled 
to room temperature.  A volume of 500µL of GC grade hexane (Fisher Scientific) 
containing the internal standard, C23:0 methyl ester (1mg/mL) (Sigma-Aldrich) and 
500µL of GC grade hexane (Fisher Scientific) was added to each tube.  Subsequently, 
2mL of deionized water was added to each sample and the samples were vortexed for 2 
minutes.  The samples were centrifuged for 5 minutes at 1000 rpm.  The upper fractions 
of the centrifuged tube contents were transferred to a disposable glass vial containing a 
small amount of anhydrous sodium sulfate (Fisher Scientific) and maintained for 2 
minutes.  The liquid was transferred to a GC vial and flushed with nitrogen then capped 
and then sampled in the 6850 Series II gas chromatograph fitted with an autosampler 
(Agilent) and analyzed using Chemstation software (Agilent). 
Reverse Transcriptase Polymerase Chain Reaction 
 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) analysis was used 
to determine if selected genes expressed by preadipocytes or adipocytes were expressed 
by the cells in each sample.  Samples of ribonucleic acid (RNA) were tested before 
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culturing cells and after Day 18 of cell culture on bead scaffolds.  Primers for the specific 
genes of interest were designed for the RT-PCR reactions. 
RNA Isolation 
 RNA was isolated from the samples to be tested.  The medium was aspirated from 
the cellular scaffolds and 2-D surfaces, and the samples were rinsed with 1mL of sterile 
PBS.  The RNA was isolated from the cells using the reagents and instructions from an 
RNeasy Mini Kit (QIAGEN, Valencia, CA).  The cell membranes of the cell samples 
were directly lysed in the well plates by adding 600µL of Buffer RLT (QIAGEN) to each 
well.  Cells grown on the microspheres were lysed directly on the surface of the beads.  
The samples were incubated for 15 minutes at room temperature in the Buffer RLT.  The 
lysate from each sample was then pipetted onto individual QIAshredder spin columns 
(QIAGEN) inserted into 2mL collection tubes.  The tubes were centrifuged for 2 minutes 
at 13,000 rpm.  After centrifugation, 600µL of 70% ethanol were added to the lysate of 
each sample and mixed well.  A volume of 700µL of the samples was pipetted into an 
RNeasy mini column (QIAGEN) placed into a new 2mL collection tube.  The tubes were 
centrifuged for 15 seconds at 13,000 rpm and the flow-through was discarded.  The rest 
of the sample solution was pipetted onto the same mini columns, and centrifugation was 
repeated for 15 seconds.  The flow-through was discarded again and 350µL of Buffer 
RW1 was added to each RNeasy column, the mixtures were centrifuged for 15 seconds at 
13,000 rpm, and the flow-through was discarded.  A solution of 10µL of DNase I stock 
solution was added to 70µL of Buffer RDD and mixed gently.  The entire solution of 
DNase I stock/Buffer RDD (80µL) was pipetted directly onto an RNeasy silica gel 
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membrane and incubated at room temperature for 15 minutes.  Another 350µL of Buffer 
RW1 was added to the RNeasy mini column, the mixture was centrifuged at 13,000 rpm 
for 15 seconds and the flow-through was discarded.  The RNeasy column was transferred 
to a new 2mL collection tube and 500µL of Buffer RPE (QIAGEN) was added onto the 
RNeasy column, then centrifuged for 15 seconds at 13,000 rpm, and the flow-through 
was discarded.  Another 500µL of Buffer RPE was pipetted onto the RNeasy column and 
centrifuged for 2 minutes at 13,000 rpm.  A volume of 50µL of RNase-free water was 
added to the RNeasy columns and the samples were centrifuged for 1 minute at 13,000 
rpm.  This step was repeated and the sample RNA was collected in a 1.5mL collection 
tube.  The final volume of each RNA sample was 100µL.  All samples were stored at -
80°C.  
Analysis of RNA Concentration and Purity 
 The concentration and purity of the isolated RNA samples was analyzed using the 
Agilent 2100 Bioanalyzer (Agilent Technologies, Inc.), 2100 Expert Software (Agilent 
Technologies, Inc.) RNA 6000 Nano Assay Kit (Agilent Technologies, Inc.), RNA 6000 
Ladder (Ambion, Inc., Austin, TX), and RNA 6000 Nano LabChip® (Caliper 
Technologies Corp., Mountain View, CA).  A gel-dye mix was prepared by adding 1µL 
of RNA 6000 Nano dye to 65µL of filtered RNA 6000 Nano gel matrix.  The gel-mix 
was vortexed to mix thoroughly and then centrifuged for 10 minutes at 1400 rpm.  After 
centrifugation, 9µL of the gel-dye mix was pipetted into the G well of the LapChip®.  
The Chip Priming Station (Agilent Technologies, Inc.) pressurized the Chip for 30 
seconds according to the manufacturer’s instructions.  Another 9µL of the gel-dye mix 
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was loaded into the 2 remaining wells on the LabChip® labeled with G.  The 5µL of 
RNA 6000 Nano Marker was added to each sample well and ladder well.  An aliquot of 
RNA 6000 ladder was heat denatured at 70°C for 2 minutes then 1µL of the ladder was 
pipetted into the ladder well on the LabChip®.  The RNA samples were thawed on ice 
and 1µL of each RNA sample were added to the samples wells for a total volume of 6µL 
per well.  The LabChip® was vortexed for 1 minute at 2400 rpm.  The chip was inserted 
into the Bioanalyzer (Agilent Technologies, Inc.) and analyzed using the Eukaryote Total 
RNA Nano program from the 2100 Expert software (Agilent Technologies) to determine 
the RNA concentration, RNA integrity number, and the 28s:18s ribosomal ratio.  The 
RNA samples were returned to -80°C storage.  RNA integrity number (RIN) was 
measured on a scale of 0 to 10, where 10 was considered high quality RNA and any 
sample that had an RIN below 8 was not used. 
RT-PCR Primers 
 Four genes were selected to test on the sample RNA.  Primers were designed for 
the following genes for use in the RT-PCR analysis: mouse growth arrest and DNA 
damage inducible gene 153 (GADD 153), mouse peroxisome proliferator activator 
receptor-gamma (PPAR-γ), mouse adipocyte-specific fatty-acid-binding protein-2 (aP-2), 
and mouse beta-actin (β-actin).  GADD 153 was selected to identify cells still as 
preadipocytes.  PPAR-γ was selected as a mid marker of adipocyte differentiation and aP-
2 was selected to identify cells in later stages of adipocyte differentiation.  β-actin was 
used as a housekeeping game.  A previous graduate student, Nicole Cavin, designed the 
primers and the primer sequences for target genes are listed in Table 1.3.  The designed 
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primer pairs for each gene were ordered (Integrated DNA Technologies (IDT), 
Coralville, Iowa) and the primers were received in lyophilized powder form and each 
primer was resuspended in a volume of RNase-free water to provide a 30µM 




















































































































































































































































 The relative level of gene expression in the RNA samples was evaluated using a 
OneStep RT-PCR Kit (QIAGEN).  To prepare the RT-PCR reactions, the manufacturer’s 
instructions were followed using a Mastercycler Gradient Thermal Cycler (Eppendorf, 
Hamburg, Germany).  The sample RNA, primers, dNTP Mix, 5x RT-PCR Buffer, RT-
PCR Enzyme Mix, and RNase-free water were thawed on ice and vortexed to mix.  A 
gene specific master mix containing 10µL of 5x buffer, 2µL of dNTP mix, 2µL of 
enzyme mix, and 1µL each of the forward and reverse primer specific to the selected 
gene was prepared for the reactions.  The appropriate volume of the master mix was 
distributed equally among 0.2 mL PCR reaction tubes (Fisher Scientific).  An amount of 
20 nanograms of template RNA was used per sample reaction.  The RNA samples were 
diluted with RNase-free water to obtain a measurable volume of RNA that could be 
pipetted into each reaction tube.  The final volume of each reaction sample was 50µL, 
reached by the addition of RNase-free water to make up the difference.  The thermal 
cycler conditions were set to include the following steps: reverse transcription of the 
mRNA sample, initial activation of PCR, denaturation of the DNA double strand, 
annealing of the primer to the DNA strands, and extension samples. 
 The optimal number of cycles for denaturation, annealing, and extension was 
determined for each primer pair.  The PCR reactions were prepared as described above.  
The template RNA was diluted with RNase-free water to obtain a measurable volume of 
RNA.  No template control (NTC) samples without the template RNA were also 
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prepared.  For the NTC samples, the total volume of 50µL was achieved by the addition 
of more RNase-free water.   
 The optimal annealing temperature for each of the primer pairs was also 
determined, and PCR reactions were prepared as described above.  The template RNA 
was diluted 1:10 with RNase-free water to obtain a volume of at least 1 µL.  Minus-RT 
control samples were prepared without the RT-PCR Enzyme Mix, and the volume was 
compensated with additional RNase-free water.  The annealing temperature in the 
thermal cycler program was set at 48°C with a gradient of 5°C, in order to encompass the 










Annealing B-actin 1 52.5 35
GADD 153 1 55.3 35
aP-2 1 53.5 35




 The RT-PCR reactions in the thermal cycler produced cDNA strands of each 
sample that were evaluated using gel electrophoresis to assess the expressed gene 
products.  The following methods for gel electrophoresis were used to evaluate the 
products of the primer optimization samples as well as the RT-PCR products of the cell 
sample reactions.  A 1X Tris Acetate EDTA (TAE) buffer was prepared by adding 900 
mL of distilled water to 100 mL of UltraPureTM 10X TAE Buffer (Invitrogen).  A 2% 
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agarose gel was prepared by dissolving 2g of agarose (Invitrogen) in 100mL of 1X Tris 
Acetate EDTA (TAE) buffer.  The agarose was heated for 2 minutes to completely 
dissolve the powder.  Ethidium bromide (Invitrogen), at a concentration of 0.5µg/mL, 
was added to the agarose to stain the gel.  The agarose was poured and allowed to solidify 
for 1 hour, creating gels with 20 wells (Horizontal Electrophoresis Systems, Fisher).  The 
electrophoresis tray was filled with 1X TAE until the gel was completely covered.  A 6X 
solution of bromophenol blue loading dye was prepared by adding 0.025g of 
Bromophenol Blue (BioRad Laboratories, Hercules, CA) to 10mL distilled water, and 
3mL of glycerol (Fisher Scientific).  The loading dye was added to each DNA sample to 
achieve a final concentration of 1X.  A volume of 12µL of each sample was loaded into 
an individual lane of the agarose gel.  A 100 base pair DNA ladder (Promega, Madison, 
WI) was loaded into the first lane of the gel.  Electrophoresis was conducted for 2 hours 
at 5 kVolts per centimeter (Model FB300, Fisher Scientific).  The gel was then viewed 
using a UV-Spectroline® BI-O-VisionTM UV/White Light Transilluminator (Spectronics 
Corporation, Westbury, New York) and a GEL LOGIC 100 Imaging System (Kodak, 
Rochester, NY).  A software package, 1D Image Analysis Software (Kodak) was used to 
analyze the gels qualitatively and to measure the relative levels of gene expression based 







 The collagen entrapped beads had an average diameter of 83µm ± 16.7µm.  The 
beads were shiny and appeared to have bubbles beneath the surface of the beads.  Most of 
the beads were spherical but some were oblong.  Beads fixed with gomori’s were 
examined using a stereoscope.  Most of the beads had a yellow tint because of Bouin’s 
fixative; a few beads looked green.   
 Polylactide beads had an average diameter of 1.02mm ± 0.21mm.  They were 
shiny with a smooth white surface.  Most of the beads were spherical but some were 
oblong.  The collagen coated polylactide beads had an average diameter of 1.10mm ± 
0.35mm.  They appeared white and opaque and were spherical in shape.  The collagen 
and linoleic acid coated polylactide beads had an average diameter of 1.11mm ± 0.27mm.  
The beads appeared white and opaque and were spherical in shape. 
Fourier Transform Infrared Spectroscopy (FTIR) 
 The presence of collagen may be determined by FTIR analysis, where one would 
expect peaks at three amide bonding wavenumbers, 1647, 1547, and 1240.  The graph 
shows a subtraction of the results from the PL beads from those of the PL beads with 
entrapped collagen.  Some small peaks appear at the bonding regions for collagen, but the 




 Gel Permeation Chromatography (GPC) 
 The weight average molecular weight (Mw) and the polydispersity of the original 
PL pellet and PL scaffolds were determined using GPC.  The as received PL had a Mw of 
193 kDaltons and a polydispersity index of 2.98 whereas the PL beads had a Mw of 205 
kDaltons with a polydispersity index of 1.86.  In the graphs, the first large peak is the 





Figure 1.3 FTIR graph.  Wavenumber 1647 (A), 1547 (B), and 1240 (C) 
 37 
received PL had a significantly higher (p<0.05) Mw than the Mw of the PL scaffold 
(Figure 1.4 A and B).  The polydispersity of as received PL and PL scaffolds were not 
different (p<0.05).   
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Differential Scanning Calorimetry 
 Analysis of the as received PL pellet showed no glass transition temperature, or 
crystallization peak during the first or second heat but a small peak for melting 
temperature was present on the first heat.  Analysis of the PL fabricated bead also showed 
no glass transition temperature, or crystallization peak during the first or second heat but 
a small peak for melting temperature was present on the first peak.  The melting peaks for 
both samples were present at approximately 150°C. 
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Figure 1.5 Sample DSC plots. (A) PL original pellet initial heating cycle, (B) PL 
scaffold first heat 
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Gas Chromatography 
 An average profile of the amount and type of fatty acid present in the beads was 
obtained.  An internal standard was added to every sample; the corresponding peak 
appeared around 47 minutes.  The calculations that were performed to determine the 




=Total fatty acid present 
Total= total amount of fatty acid in entire sample 
ISTD= internal standard added 
Analysis of the PL beads revealed two fatty acids that were present in large 
amounts, capric acid and palmitic acid.  Analysis of the PL+C beads also revealed large 
amounts of capric and palmitic acid.  Analysis of the PL+C+L beads did not reveal a 
discernible peak for capric acid, but did reveal a peak for palmitic acid.  The latter 
analysis revealed a peak for linoleic acid, as well as many more peaks than those found 
on analysis of the other two bead systems.  The linoleic acid was also tested to determine 




Stir Flask LIVE/DEAD 
 No cells attached to the PL beads by Day 7; rather the cells aggregated and 
floated in the medium.  Cells aggregated on the some of the collagen enhanced beads, 
causing select beads to aggregate; however, not all of the beads supported cell 
attachment.  By Day 13, some cells had attached to a few PL beads, mainly on the 






smaller beads.  Most of the PL beads with entrapped collagen were covered with cells 
and aggregated in large numbers.  
 
Cellular Imaging 
 Figure 3 shows the cells seeded on tissue culture treated polystyrene well plates in 
DMEM, i.e., the “negative controls”, and shows cells seeded on tissue culture treated 
polystyrene well plates in DMEM supplemented with 20 µL linoleic acid, i.e., the 
“positive” controls.  At Day 4, both cell populations were visually similar to 
A B 
C D 
Figure 1.7 Live/Dead photographs of cells seeded on PL beads (A), PL beads with 
entrapped collagen (B) at Day 7, and PL beads (C) and PL beads with entrapped 
collagen at Day 14.  All images were taken at a 50X total magnification 
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preadipocytes.  By Day 18, cells in the negative control group appeared to produce small 
lipid droplets, but retained their fibroblast-like appearance.  Cells cultured with 20 µL 
linoleic acid appeared to produce many lipid droplets, some of which coalesced into a 
single large lipid droplet in the cell.  Many more cells in the positive control culture 
produced lipid by Day 18 than cells in the control culture.  
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Figure 1.8 Cells seeded on polystyrene.  Negative control Day 4 (A) Positive control Day 
4 (B), Negative control Day 10 (C), Positive Control Day 10 (D), Negative control Day 
18 (E), Positive control Day 18 (F) 
 
 47 
Lactic Acid/ Glucose Measurements 
 The anaerobic metabolic activity of the cells was analyzed by testing the amount 
of lactic acid produced and glucose consumed by the cells at every medium change.  
Increases in lactic acid production indicate the cells are metabolically active.  All of the 
samples except for PL and PL+C+L had significantly increased (p<0.05) the amount of 
lactic acid on Day 18 compared to Day 4. Between Day 10 and Day 18, all groups 
showed a significant increase (p<0.05) in the amount of lactic acid produced.  The 
negative and positive control groups produced significantly higher (p<0.05) amounts of 
lactic acid by Day 18 than the other (experimental) samples.   
 
Figure 1.9 Lactic acid concentrations for the different scaffolds over 18 Days in culture. 
Standard deviation of 4 samples 
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The PL+C+L cellular group was the only group that did not have a significant 
decrease (p<0.05) in the amount of glucose between Day 4 and Day 18, although 
differences existed for this group between Day 2 and 18.  Between Day 10 and Day 18, 
all groups significantly decreased (p<0.05) in glucose concentration.  On Day 18, the 
negative control group and the positive control group had significantly lower (p<0.05) 
glucose concentrations than any of the other groups.  
 
Figure 1.10 Glucose consumption for different scaffolds during 18 Days in culture. 




 Live/dead pictures were taken at Days 4, 10, and 18 for each of the 3-D scaffolds.  
Pictures of cell growth on Day 4 are shown in Figure 1.6.  No cells visibly grew on the 
PL beads by Day 4, but cells grew in clusters in the medium.  There were no dead beads 
present.  Cells began attaching to the PL+C beads by this time point, and some beads 
were almost completely covered by live cells.  Dead cells were co-localized with live 
cells on some beads, while others were completely acellular.  The cells began to grow on 
the PL+C+L, almost completely covering the beads.  
 
Figure 1.11 Live/Dead results showing cells seeded on PL beads (A), PL+C beads (B), 
and PL+C+L beads (C).  All images were taken on Day 4 at 25X total magnification 
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Cells began growing on some of the PL beads (Figure 1.7) by Day 10.  Many of 
the PL scaffolds did not support cell attachment.  The beads that did support cell 
attachment also had attached dead cells.  Some PL+C beads were completely covered by 
live cells, and almost all of the beads had some live cell attachment.  A small number of 
dead cells were visible on the beads.  Some PL+C+L beads were completely covered by 
live cells, and most of these beads had live cells attached.  A small numbers of dead cells 
were visible on the PL+C+L beads. 
 
Figure 1.12 Live/Dead pictures of cells seeded on PL beads (A), PL+C beads (B), and 
PL+C+L beads (C).  All images were taken on Day 10 at 25X total magnification 
 
 51 
The PL scaffolds had a minimal number of beads covered with cells at Day 18 
(Figure 1.8).  Some of beads that had attached cells appeared to be almost completely 
covered with cells.  Some of the attached cells bridged two or more beads.  Cells were 
present on the PL+C beads and most of the beads appeared to be completely covered by 
the cells.  There were more cells present on the beads than on Day 10.  A minimal 
number of dead cells were visible on all of the beads.  The PL+C+L beads also had cells 
present on most of the beads, where most beads appeared to be completely covered by 
cells.  A minimal number of dead cells were visible on all of the beads. 
 
Figure 1.13 Live/Dead photographs of cells seeded on PL beads (A), PL+C beads (B), 
and PL+C+L beads (C).  All images taken on Day 18 at 25X total magnification 
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Triglyceride Determination Assay 
 The total amount of triglyceride produced by the cells per scaffold type was 
determined at each time point.  The triglyceride concentrations measured for each type of 
sample at each time point are summarized in Table 1.5.  The triglyceride content for the 
cells seeded on the negative control, positive control, and the PL beads did not 
significantly increase (p<0.05) over the course of 18 Days.  Cells seeded onto PL+C 
beads and PL+C+L beads, had a significant increase (p<0.05) in triglyceride from Day 4 
to Day 18.   
 
Table 1.5: Triglyceride Measured in Cell Samples 
Day Scaffold Average Triglyceride Conc. (µM) 
4 
Negative 
Control 42.3 ± 5.56 
4 
Positive 
Control 41.8 ± 14.69 
4 PL 48.63 ± 6.88 
4 PL+C 30.4 ± 5.26 
4 PL+C+L 33.63 ± 4.36 
10 
Negative 
Control 46.8 ± 3.53 
10 
Positive 
Control 42.2 ± 3.21 
10 PL 53.48 ± 5.15 
10 PL+C 52.04 ± 3.00 
10 PL+C+L 51.7 ± 6.54 
18 
Negative 
Control 49.7 ± 4.96 
18 
Positive 
Control 51.09 ± 2.54 
18 PL 39.66 ± 12.92 
18 PL+C 61.29 ± 1.47 
18 PL+C+L 49.4 ± 10.14 
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As shown in the graph, cells grown on PL beads had a significantly higher 
(p<0.05) concentration of triglyceride than cells grown on PL+C beads and PL+C+L 
beads by Day 4.  Cells cultured with 20 µL linoleic acid (positive controls) had a 
significantly lower (p<0.05) concentration of triglyceride than the cells grown on each of 
the bead scaffolds by Day 10.  At Day 18, cells grown on PL+C beads had a significantly 
higher (p<0.05) concentration than cells grown on PL beads and cells grown on PL+C+L 
beads, but had a non-significantly different concentration than the cells in the two 2-D 
control groups.  
 
Figure 1.14 Concentrations of triglyceride produced by cells at each time point for each 
scaffold 
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Total Fatty Acid Content 
 The amount and type of fatty acid produced by the cells on each substrate was 
determined for each time point and shown in Figure 1.15.  The positive control had the 
largest amount of fatty acid on Day 18 than any other group.  These cells also had a 
significant increase (p<0.05) in the total amount of fatty acid between Day 10 and Day 
18.  Cells grown on PL beads had significantly decreased (p<0.05) in the total amount of 
fatty acid produced from Day 10 to Day 18.  Cells grown on PL+C and PL+C+L 
scaffolds did not significantly (p<0.05) increase or decrease in the total amount fatty acid 
from Day 4 to Day 18.  On Day 4, there were no significant differences between any of 
the groups.  On Day 10, cells grown on the negative control scaffold had a significantly 
lower (p<0.05) amount of fatty acid than cells grown on PL beads and on PL+C beads.  
Also, the cells grown with 20 µL linoleic acid had a significantly lower (p<0.05) amount 
of total fatty acid than cells grown on PL+C beads.  On Day 18, fatty acid content of cells 
grown on PL+C beads and PL+C+L beads were not significantly different (p<0.05) from 




Figure 1.15 Total amount of fatty acid content in every sample at each time point 
 
 The fraction of linoleic acid that contributes to the total fatty acid content is 
displayed in Figure 1.16.  The calculations to determine the percentage of linoleic acid in 







*100=Percentage of linoleic acid present 
Area= area of peak measured 
ISTD= internal standard 
Total= total amount of fatty acid in entire sample 
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No measurable amounts of linoleic acid were detected in the cells grown on the 
PL+C+L scaffold at any time point.  One sample, with cells grown on PL scaffolds, and 
one sample, with cell population grown on PL+C scaffolds, had linoleic acid present on 
Day 10, but no other cell populations grown on these two scaffolds had linoleic acid 
present at any time point.  Cells grown on the negative control scaffold had incorporated 
levels of linoleic acid on Days 4 and Day 18.  There was a significant increase (p<0.05) 
in the amount of linoleic acid in the cell population grown on the control scaffold 
between Day 4 and Day 18.  Cells cultured with 20 µL of linoleic acid (positive control) 
had a significantly larger (p<0.05) amount of intracellular linoleic acid than any other 
group at any time point.  The amount also significantly increased (p<0.05) between Day 4 

















































Figure 1.16 Percentage of linoleic acid in every sample at each time point 
 
RT-PCR 
RNA Purity and Concentration 
 The samples from the 2-D scaffolds, and from the PL+C+L scaffolds had RINs of 
8 or better, but the samples from the PL and PL+C scaffolds did not have high enough 
RINs and were not included in further analysis.  The concentration of RNA, the rRNA 
ratio, and the RIN for each sample for Day 18 can be found in Table 1.6.  There is no 









Day 0 3 0 N/A
Control 113 2.4 10
Control 102 2.7 N/A
Control 79 23.5 10
Control 100 2.9 N/A
20uL 72 2.6 10
20uL 30 2.6 10
20uL 110 2.5 10
20uL 73 2.5 10
PL+C+L 13 3.1 9.9
PL+C+L 12 2.8 9.3
PL+C+L 10 3.0 9.5
PL+C+L 6 0 N/A




 All of the cell populations from the negative control, the positive control, and 
from the PL+C+L scaffolds expressed β-actin.  The samples that did not have an RIN 
number also expressed β-actin.  Three cell populations seeded on the negative control 
expressed GADD 153, while only one cell population expressed aP-2.  One cell 
population seeded on the PL+C+L beads expressed GADD 153 while two cell 
populations expressed aP-2; the groups expressing aP-2 were mutually exclusive from the 
groups that expressed GADD 153.  The cell population that expressed GADD 153 was 
also the same group that did not have an RIN and had a ratio of 18s:21s of zero.  All four 
cell populations cultured in 20 µL expressed GADD 153, while only two populations 
expressed aP-2.  PPAR-γ was not detected in any samples.  Also, Day 0 samples (before 
seeding the cells onto scaffolds) were tested and the resulting gel showed a weak band for 
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β-actin, with no expression of GADD 153 or aP-2.  The latter cannot be trusted because 
of the 0 ratio of 18s:21s and the lack of an RIN. 
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Figure 1.17 Gel electrophoresis results for cells seeded on negative controls, PL+C+L 








The main objective of this research was to design 3-D polymer scaffolds that are 
viable for preadipocyte growth and differentiation and to assess the behavior and gene 
expression of cells grown on these scaffolds.  Polylactide, a synthetic polymer, was used 
to fabricate control scaffolds to compare with polylactide scaffolds coated with collagen 
or collagen and linoleic acid.  Each of these scaffolds was tested to determine its potential 
in an injectable composite for breast tissue engineering. 
Polylactide beads were fashioned and used as the base for each type of scaffold 
created in this study.  As an unmodified microsphere, polylactide has a smooth, 
hydrophobic surface.  Cells have a low affinity to polylactide; to increase its cellular 
affinity, it is desirable to modify the polylactide to a more desirable configuration by 
altering the macroscopic structure or the surface characteristics.  In order for 3-D 
polylactide scaffolds to have the potential to induce new adipose tissue formation, it will 
be necessary for these microspheres to support preadipocyte cell attachment. 
Collagen was chosen as the surface coating material for polylactide because of its 
biodegradable and nontoxic properties.  It is hydrophilic and, because it is a natural 
material, has cell recognition sites that facilitate cellular attachment.  Linoleic acid was 
coated onto a set of beads with collagen to encourage preadipocyte differentiation and, 
eventually, adipocyte lipid filling. 
Initially, collagen was added to a solution of polylactide before being made into 
beads.  Beads from this mixture were almost 13 times smaller than PL beads.  Fibroblasts 
were shown to have a high affinity to these collagen encapsulated PL beads, shown by 
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the larger number of cells attached to these scaffolds than the PL microspheres and the 
continual cellular proliferation on the collagen encapsulated beads.  Collagen inside the 
beads could have increased cell affinity once released from the bead, due to the 
collagen’s compatible chemistry, although collagen was not conclusively proven to be 
present by Gomori’s One Step Trichrome or FTIR.  The dramatic difference in size 
caused by the addition of collagen is also a likely reason cells had a greater affinity for 
these beads [32, 33].  These beads also appear to contain bubbles (not shown), which may 
have affected the surface of the beads and therefore affected cell attachment and growth.  
Although one or more of these reasons could have affected cell affinity for these beads, 
the increased cellular affinity is most likely due to the smaller size of these beads. 
Since collagen was not proven present in the previous beads, collagen was added 
to the polylactide using a different method. Hong and colleagues created a way to graft 
collagen to the surface of PL beads, thus ensuring collagen was present on the surface of 
the beads [34].  For one set of beads, linoleic acid was added to the solubilized collagen 
before coating.  Both types of scaffolds were tested with preadipocytes. 
In the final cell test, the scaffolds tested were PL beads, PL beads coated with 
collagen and PL beads coated with collagen and lipid.  The coating of the scaffold 
influenced cellular attachment and behavior as showed from the LIVE/DEAD® assay, 
triglyceride assay, gas chromatography, RT-PCR, and lactic acid/glucose measurements.  
The preadipocytes cultured on both types of coated PL scaffolds attached to the scaffolds 
at an early time point, proliferated, and maintained or increased in total fatty acid content 
and triglyceride concentration throughout the entire study.  The preadipocytes cultured on 
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the uncoated PL scaffolds had a later time point for attachment, and either maintained or 
decreased in total fatty acid content and triglyceride concentration; only a few scaffolds 
supported cell attachment.   
The metabolic activity of the cells was determined by the lactic acid/glucose 
assay.  Glucose, supplied in the medium, is the “food” for the cells and decreases in 
glucose concentration in the medium indicate an increase in overall metabolic activity.  
Medium from all of the scaffolds continually decreased in glucose concentration from the 
second Day of the study to the last Day of the study.  Lactic acid is waste produced by 
active cells and increases in lactic acid concentration in the medium indicate overall 
metabolic activity.  In all scaffolds except PL beads and PL+C+L, beads lactic acid 
concentration increased between Day 4 and Day 18.  All scaffolds increased in lactic acid 
production between Day 10 and Day 18.  
These results suggest that the cells are proliferating on the all of the scaffolds.  
Lactic acid results for cells cultured on PL and PL+C+L beads show there was possibly a 
delay in significant cell growth until Day 10, although glucose consumption had 
increased since the beginning of the culture.  For the PL scaffolds, this delay in 
significant lactic acid production is due to the fact that cells have a low affinity for the 
surface of the beads so have a harder time attaching and then dividing.   
Interestingly, all scaffolds significantly decreased in lactic acid concentration 
from Day 4 to Day 6 and all scaffolds except for PL and PL+C+L increased significantly 
from Day 2 to Day 4.  The increase on Day 4 is because the cells that attached on Day 2 
are dividing.  There was no increase for cells cultured on PL beads; far fewer cells 
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attached to these relatively hydrophobic scaffolds and these cells probably did not divide 
immediately.  The introduction of the linoleic acid may have disturbed the natural 
progression of cellular attachment and division.  Cells could attach to the beads, but once 
there, many of the cells may have focused on remodeling the linoleic acid before 
dividing, which would explain why there is a non-significant increase. 
LIVE/DEAD images for the 3-D scaffolds show quantitatively that cells grown on 
all of the scaffolds increased in number during the culture period, but at different rates.  
Cells grown on PL beads took the longest to start growing on the beads and the fewest 
cells visible.  It was not until Day 10 that any cells were seen growing on the PL beads 
and at Day 18, only a few beads were partially covered with cells.  For cells grown on 
both PL+C and PL+C+L beads, cells had already attached to the beads by Day 4, 
qualitatively increasing in cell number at each time point.  By Day 18, most of the beads 
of both material types were almost completely covered.  For all bead groups, beads 
without live cell attachment also did not have dead cell attachment, indicating that cells 
never attached to these beads. 
It was expected that a larger number of cells would attach to the coated beads due 
to the presence of collagen.  Research by von Heimburg and coworkers showed the 
affinity of preadipocytes to collagen scaffolds and that the cells also differentiated into 
mature adipocytes on the collagen scaffolds [35].  It was easier for the cells to attach to 
the collagen than the PL surface because the collagen is a natural, hydrophilic, 
nonantigenic material and it is recognizable to the cells.  Both types of coated beads 
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facilitated improved cell attachment and cell proliferation rate as compared with the plain 
PL beads.   
The triglyceride and total fatty acid assays measured production of triglyceride 
and fatty acid, both of which are produced by maturing preadipocytes and adipocytes.   
Triglycerides are composed of a glycerol and three fatty acids.  The triglyceride assay 
measures glycerol concentration while gas chromatography breaks down all complex 
fatty acids to measure each fatty acid individually.  The results from the triglyceride 
assay should correlate with the results from the gas chromatography assay.  Increases in 
either could be due to an increase in cell number or due to an increase in cell 
productivity.  Some of the triglyceride groups had a large standard deviation due to 
inconsistent cell growth between the different samples in each group. 
Cells grown on the negative control 2-D surfaces did not display an increase in 
triglyceride or total fatty acid content, but did display a significant increase in linoleic 
acid from Day 4 to Day 18.  The cells cannot produce linoleic acid, so any linoleic acid in 
the cells must be extracted from the medium or scaffolds and then incorporated into the 
cells.  This increase indicates that linoleic acid was present in the medium and that the 
cells were incorporating fatty acids.  Images taken of these cells showed that most cells 
still maintained fibroblast-like morphologies on Day 18, but that some had developed 
rounded morphologies.  Fischbach and coworkers showed that preadipocytes did not 
differentiate in culture without differentiation inducers [36].  Cells cultured on the 
positive control scaffolds increased in total fatty acid content between Days 10 and 18 
and specifically increased in linoleic acid between Days 4 and 10.  Images on Day 10 
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showed some cells with rounded morphology and, by Day 18, some cells with lipid 
droplets present.  The addition of linoleic acid to the medium, with no other 
differentiation inducers, facilitated a quicker transition from a fibroblast-like state to a 
round, lipid filled state. 
The cells cultured on the 3-D scaffolds developed more slowly than the cells 
cultured on the 2-D scaffolds.  Cells cultured on PL beads had constant triglyceride 
production and a decrease in total fatty acid content over the entire culture period.  Since 
the lactic acid/glucose measurements indicate that cell numbers increased between Days 
10 and 18, the cells created less triglycerides and fatty acids as time progressed.  Samples 
from both PL+C and PL+C+L scaffolds increased in triglyceride but not in total fatty 
acid.  This occurrence is most likely due to an increase in the number of cells as time 
progressed, as indicated by the lactic acid/glucose measurements.  The results from the 
triglyceride assay and total fatty acid assay should show similar trends for each of the 
samples, but there were significant differences between the results derived from the two 
assays.  This difference is most likely due to the fact that the procedure for gas 
chromatography has not been optimized for cells grown on polymer beads.  
Only two individual cultures, of all the 3-D scaffolds samples, had linoleic acid 
present and it was only present on Day 10.  These samples were not extracted from the 
cells cultured on the PL+C+L beads, so the linoleic acid was not from the initial coating 
of the beads.  The linoleic acid was not present in other cultures from the same group and 
sample day, and was not present in previous or later days.  This result therefore is most 
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likely an artifact due to from insufficient rinsing of these two samples on that particular 
day, rather than as a result of cells incorporating the linoleic acid. 
RT-PCR was used to analyze gene expression of specific preadipocyte and mature 
adipocyte genes.  The expression of these genes helps to determine the extent of cell 
differentiation.  Gene expression was analyzed for cells cultured on the control 2-D 
scaffolds, cells cultured on 2-D scaffolds with 20 µL of linoleic acid, and cells cultured 
on PL+C+L scaffolds.  An RIN of less than 8 is not viable for further testing.  Cells 
cultured on PL beads and PL+C beads were extremely low in number and therefore did 
not have enough viable RNA to test for gene expression. 
The primers for β-actin, GADD 153, PPAR-γ, and aP-2 were designed by Nichole 
Cavin, though the optimal primer conditions were different than previously recorded 
[37].  PPAR-γ was not detected in any sample.  This is most likely due to incorrectly 
designed primers or conditions for the assay were not properly optimized for this primer.  
The cells grown on the control 2-D scaffold expressed GADD 153 in three of the four 
samples, and one of those samples also strongly expressed aP-2.  All four of the samples 
of cells supplemented with 20 µL linoleic acid expressed GADD 153; two of those 
samples expressed it very strongly.  Two of the cultures expressed aP-2 weakly.  These 
results indicate that both 2-D scaffolds had cell populations consisting of preadipocytes 
and mature adipocytes.  Only one sample of cells grown on PL+C+L beads expressed 
GADD 153, while two different samples grown on these beads expressed aP-2 weakly. 
GADD 153 is a growth arrest gene that is expressed during a cell’s exit from the 
growth cycle and entry into differentiation.  It has been reported that GADD 153 is 
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expressed during growth arrest in preadipocytes, then down regulated as the 
preadipocytes enter the differentiation cycle [38].  However, Darlington and coworkers 
report that GADD 153 is expressed at low levels in confluent preadipocytes and is 
suppressed throughout clonal expansion before adipogenesis [39].  GADD 153 is 
elevated on Day 4 of differentiation and remains elevated throughout differentiation [39].  
Literature reports do agree that GADD 153 is not expressed until cells become confluent.  
The expression of GADD 153 in the results published here indicate that the cells from all 
three scaffold types tested are, at the very least, entering the differentiation stage by 
undergoing growth arrest, which is the first stage of differentiation.   
Two cells populations grown on the control 2-D scaffold and two cell populations 
grown on the 2-D scaffolds with 20uL linoleic acid supplement expressed both GADD 
153 and aP-2.  Since aP-2 is only expressed in mature adipocytes, these results indicate 
that the cell populations of these scaffolds are a heterogeneous mix of preadipocytes and 
mature adipocytes.  Two populations of cells grown on PL+C+L beads expressed aP-2 
but did not express GADD 153, although one other population of cells grown on 
PL+C+L did express GADD 153.  This result indicates that cells grown on these 
scaffolds are also a heterogeneous mix of preadipocytes and mature adipocytes. 
Since there are conflicting reports regarding the timing of GADD 153 expression 
during preadipocyte differentiation, and without knowing the expression profile for 
PPAR-γ, it is difficult to know why some cell populations are not expressing GADD 153 
at all.  The samples that contain no GADD 153 could either be preadipocytes before 
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growth arrest, preadipocytes undergoing clonal expansion, or preadipocytes undergoing 
differentiation, depending on which previous research is to be believed.   
 Even though cells could attach to all of the microspheres, regardless of the surface 
chemistry, the cell numbers are different when comparing those cultivated on PL surfaces 
and those cultivated on collagen PL surfaces.  The addition of collagen to the surface of 
the beads significantly increased the cell attachment rate and possible growth rate.  
Relatively more cells were observed on the beads with collagen and with collagen and 
linoleic acid surfaces than on the PL beads.  The collagen presented a compatible surface 
for the cells to recognize and bind to. 
 The effect of adding linoleic acid to the surface of the beads was not clearly 
determined.  McNeel and coworkers found that the effect of linoleic acid on 
preadipocytes was the same no matter the type of isomer [40].  This is why linoleic acid 
and not conjugated linoleic acid was tested on these beads.  However, Satory and Smith 
reported that conjugated linoleic acid inhibits preadipocyte proliferation and promotes 
lipid filling of these cells over a range of concentrations [30].  Also, since conjugated 
linoleic acid is composed of positional and geometric isomers of linoleic acid, the type of 
linoleic acid may have different effects on preadipocytes [41, 42].  The reason we did not 
see any significant differences between the beads coated with collagen and the beads 
coated with collagen and linoleic acid is likely due to the concentration of linoleic acid on 
the surface of the beads.  One linoleic acid concentration was chosen in order to simply 
determine if linoleic acid could be added to the surface of the beads. 
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 The DSC results indicate that the original polymer used to construct the PL 
scaffolds is semi-crystalline.  There were no DSC-induced crystallization peaks but a 
melting peak was present.  The polylactide microsphere fabrication process did not affect 
the crystallinity of the polymer.  
 The fabrication of the PL beads did decrease the molecular weight of the polymer.  
The creation of the PL beads likely cleaves the larger molecular weight chains, causing a 
decrease in overall weight average molecular weight.  The polydispersity of a polymer is 
the ratio of weight average molecular weight to the number average molecular weight, 
and is an indication of the distribution of molecular weights within the polymer.  There 
was no significant difference between the as-received PL and the PL beads indicating that 
fabrication of the beads did not affect distribution of the molecular weights. 
 The scaffolds selected were tested with the goal of eventual use in an injectable 
composite system.  The composite system may include different types of beads that will 
serve specific purposes.  Collagen and linoleic acid coated beads could serve as cell 
attachment sites, while PL beads could serve another purpose other than cellular 
interaction.  The fabrication and degradation of PL., as well as the cellular and tissue 
reaction to PL have been well documented by many researchers [18, 43].  PL could serve 
many functions in a composite system, such as a bulking agent, a mechanical support 






 In the initial study, collagen was encapsulated in polylactide beads, which caused 
the beads to be 13 times smaller than polylactide beads.  These beads were cultured with 
fibroblasts in stir flasks and tested for cellular viability.  Cells cultured with the collagen 
encapsulated beads attached to the beads and proliferated on them through out the entire 
culture period, while cells cultured with the polylactide beads did not attach to the beads 
but aggregated together instead.  Collagen was not proven to be present in the beads and 
therefore were not tested further. 
Two types of coated polylactide beads were created and tested in a cell culture of 
preadipocytes.  Coating the polylactide affected cellular attachment, cellular proliferation, 
and triglyceride and fatty acid production.  The collagen coating increased cellular 
attachment, proliferation, and triglyceride production of the preadipocytes compared to 
that resulting from culture with uncoated polylactide beads.  The concentration of linoleic 
acid in the coating did not have a measurable affect on cellular activity, but linoleic acid 
added to medium on a 2-D plate increased fatty acid production in preadipocytes.  
Collagen coated beads show promise to be used in a tunable system as cellular carriers 
and for the promotion of cellular growth.  Coated and uncoated scaffolds can be used in 
combination to form an injectable composite system, the coated beads functioning as a 







Future studies should research an optimal concentration of linoleic acid for 
inducing differentiation in preadipocytes. 
Studies should research coating different concentrations of linoleic acid on the 
surface of microspheres. 
Further studies should research the effects of differing concentrations of tannic 
acid on collagen and linoleic acid content in the surface coating. 
Other types of fatty acid should be researched as a coating for microspheres. 
Real time RT-PCR and more preadipocyte and adipocyte specific genes should be 
used to evaluate the gene expression. 
More research should go into optimizing the gas chromatography procedure for 
polymer beads. 
A co-culture of preadipocytes with other cells found in the breast should be 
researched further. 
Further studies should determine an appropriate hydrogel carrier for the injectable 
beads. 
Future studies should be designed to test the effects of shear forces from injection 













Figure A-1: 12-well plate layout for assessment of cellular activity and differentiation on 
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